Sinonasal Cancer Multi-institution Study begins in United States

Mayo Clinic is enrolling patients into the clinical trial investigating Prospective Sinonasal Cancer Multi-institution Study.

This is a multi-institution prospective study of patients with sinonasal malignancies. The goal of this study is to learn more about the course of sinonasal cancer, treatment outcomes, and patient quality of life. In addition, central mutational and genomic analysis of tumor tissue will be evaluated.

The trial is designed to enroll male and female 99 years and younger and is being conducted in the Mayo Clinic in Rochester, Rochester, Minnesota, United States.

The study start date is January 1, 2021.

Patients undergoing treatment for sinonasal cancers can be enrolled into this study.

Among the inclusion criteria are:

  • Subjects between the ages of 30 days (non-inclusive) and 99 years (inclusive)
  • Patients with a diagnosis of sinonasal cancer
  • Patients undergoing treatment at Mayo Clinic

This page provides a more detailed overview of this clinical trial:

Clinical Research News